{"url_path":"/sec/dmaa/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/2028614/0001213900-26-056798-index.html","accession_number":"0001213900-26-056798","cik":"0002028614","ticker":"DMAA","issuer_name":"Drugs Made In America Acquisition Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2028614/0001213900-26-056798-index.html","primary_entity_key":"0002028614","primary_entity_name":"Drugs Made In America Acquisition Corp."},"word_count":35,"has_tables":true,"body_markdown":"Item 1. Legal Proceedings.\n\n \n\nTo the knowledge of our management, there is no\nlitigation currently pending against us, any of our officers or directors in their capacity as such or against any of our property."}